Cardiol Therapeutics (CRDL) Earnings Date & Reports
A.I. Advisor
published Earnings
CRDL is expected to report earnings to rise 38.36% to -10 cents per share on November 12
Q3'24
Est.
$-0.10
Q2'24
Beat
by $0.03
Q1'24
Missed
by $0.01
Q4'23
Missed
by $0.01
Q3'23
Beat
by $0.02
The last earnings report on August 15 showed earnings per share of -7 cents, beating the estimate of -10 cents. With 190.96K shares outstanding, the current market capitalization sits at 124.33M.